BridgeBio have demonstrably improved this development of the new treatment for amyloid heart disease, employing the investigational drug. Initial trial results reveals potential benefits for patients diagnosed with a https://bridgebio397849.dgbloggers.com/42559404/bridgebio-advances-amyloidosis-treatment-with-the-drug